Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$4.6MFederal grants as PI5 awards
1Patents grantedLatest Mar 31, 2026
35Papers853 citations
Federal awards and patents by year
AwardsPatents
5 awards · $4.6M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 7, 2019 | NIH | SBIR Phase I Matrix Metalloproteinase-2/-9 Inhibitor For The Treatment Of ALS | $458K | AQUILUS PHARMACEUTICALS INC |
| Jul 27, 2016 | NIH | SBIR Phase II Development of a MMP Inhibitor for Neuropathic Pain | $1.4M | AQUILUS PHARMACEUTICALS INC |
| Sep 23, 2015 | NIH | SBIR Phase I Orally active MMP inhibitor for the treatment of bone cancer pain | $287K | AQUILUS PHARMACEUTICALS INC |
| Aug 1, 2015 | NIH | SBIR Phase II Development of a MMP Inhibitor for Neuropathic Pain | $1.9M | AQUILUS PHARMACEUTICALS INC |
| Jul 23, 2015 | NIH | SBIR Phase II Development of a MMP Inhibitor for Neuropathic Pain | $556K | AQUILUS PHARMACEUTICALS INC |
2 patents as inventor
- US 12589090AQUILUS PHARMACEUTICALS INCMar 31, 2026
- US AQUILUS PHARMACEUTICALS INC—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#307
Awards as PI#417
Patents#155
Companies
- AQUILUS PHARMACEUTICALS INCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.